The Role of Adjuvant Systemic and Intravitreal Corticosteroids in Fungal Endophthalmitis Treatment

被引:4
作者
Azhari, Jamal [1 ]
Tetelbom, Pedro S. [1 ]
Sallam, Ahmed B. [1 ]
机构
[1] Univ Arkansas Med Sci, Harvey & Bernice Jones Eye Inst, Dept Ophthalmol, Little Rock, AR 72205 USA
关键词
fungal endophthalmitis; inflammatory response; pathobiology; systemic corticosteroids; intravitreal corticosteroids; Candida; molds; yeast; Aspergillus; antifungals; FACTOR-KAPPA-B; YEAST PHAGOCYTOSIS; ENDOGENOUS ENDOPHTHALMITIS; MACROPHAGE CULTURES; ARACHIDONIC-ACID; DEXAMETHASONE; INHIBITION; SUPPRESSION; GLUCOCORTICOIDS; MECHANISMS;
D O I
10.3390/jof9121147
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Endophthalmitis refers to inflammation involving internal ocular structures, including the anterior and posterior eye segments, associated with infectious agents, most commonly bacteria and fungi. This review focuses on endophthalmitis caused by fungi. Medical and surgical management are the two main treatment modalities for fungal endophthalmitis, with medical management utilizing systemic or intravitreal antifungals. The use of systemic or intravitreal corticosteroids as an adjuvant treatment to dampen the severity of inflammation is controversial. Based on the pathobiology of fungal endophthalmitis as well as the mechanism of action of corticosteroids, it was hypothesized that corticosteroids affected the immune response against fungal infection. In vitro studies mostly carried out during the 1980s showed that dexamethasone plays a role in the suppression of phagocytosis of yeasts and demonstrated the facilitation of yeast proliferation by dexamethasone. In vivo studies analysis was compromised entirely of retrospective studies describing steroid use in fungal endophthalmitis, with the outcomes of the patients in these studies varying greatly and often being anecdotally noted, thus difficult to discern any definitive results. Given the limited clinical data and the heterogeneity of the existing studies, additional experimentation human studies with clinical trials or observations over more extended periods analyzing the effect of systemic and intravitreal corticosteroids in fungal endophthalmitis are needed before definitive conclusions can be drawn.
引用
收藏
页数:11
相关论文
共 41 条
[1]  
Anand A R, 2000, Indian J Ophthalmol, V48, P123
[2]   SUPPRESSION OF PHAGOCYTOSIS BY DEXAMETHASONE IN MACROPHAGE CULTURES - INABILITY OF ARACHIDONIC-ACID, INDOMETHACIN, AND NORDIHYDROGUAIARETIC ACID TO REVERSE THE INHIBITORY RESPONSE MEDIATED BY A STEROID-INDUCIBLE FACTOR [J].
BECKER, J ;
GRASSO, RJ .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (06) :839-847
[3]   DEXAMETHASONE ACTION INHIBITS THE RELEASE OF ARACHIDONIC-ACID FROM PHOSPHATIDYLCHOLINE DURING THE SUPPRESSION OF YEAST PHAGOCYTOSIS IN MACROPHAGE CULTURES [J].
BECKER, JL ;
GRASSO, RJ ;
DAVIS, JS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (02) :583-590
[4]   Endogenous Endophthalmitis - An 18-year review of culture-positive cases at a tertiary care center [J].
Binder, MI ;
Chua, J ;
Kaiser, PK ;
Procop, GW ;
Isada, CM .
MEDICINE, 2003, 82 (02) :97-105
[5]   Fungal pathogens-a sweet and sour treat for toll-like receptors [J].
Bourgeois, Christelle ;
Kuchler, Karl .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 :142
[6]   FUNGAL ENDOPHTHALMITIS Fourteen Years' Experience From a Center in India [J].
Chakrabarti, Arunaloke ;
Shivappakash, M. R. ;
Singh, Ramandeep ;
Tarai, Bansidhar ;
George, Varghese K. ;
Fomda, Bashir A. ;
Gupta, Amod .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (10) :1400-1407
[7]   Endogenous Fungal Endophthalmitis: Causative Organisms, Treatments, and Visual Outcomes [J].
Chen, Kuan-Jen ;
Sun, Ming-Hui ;
Chen, Yen-Po ;
Chen, Yi-Hsing ;
Wang, Nan-Kai ;
Liu, Laura ;
Chao, An-Ning ;
Wu, Wei-Chi ;
Hwang, Yih-Shiou ;
Lai, Chi-Chun .
JOURNAL OF FUNGI, 2022, 8 (06)
[8]   Fungal Endophthalmitis After Descemet Stripping Automated Endothelial Keratoplasty-A Case Report [J].
Chew, Annabel C. Y. ;
Mehta, Jodhbir S. ;
Li, Lim ;
Busmanis, Inny ;
Tan, Donald T. H. .
CORNEA, 2010, 29 (03) :346-349
[9]   INTRAVITREAL CORTICOSTEROIDS IN THE TREATMENT OF EXOGENOUS FUNGAL ENDOPHTHALMITIS [J].
COATS, ML ;
PEYMAN, GA .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1992, 12 (01) :46-51
[10]   Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients [J].
Corredores, Jamel ;
Hemo, Itzhak ;
Jaouni, Tareq ;
Habot-Wilner, Zohar ;
Kramer, Michal ;
Shulman, Shiri ;
Jabaly-Habib, Haneen ;
Al-Talbishi, Ala'a ;
Halpert, Michael ;
Averbukh, Edward ;
Levy, Jaime ;
Deitch-Harel, Iris ;
Amer, Radgonde .
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (01) :97-105